Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Axogen, Inc.
The company completed buying or selling a business or major assets. An 8-K is the notice a US public company must file within four business days of a major event.
www.axogeninc.comAI Executive Summary
AI-powered analysis of 8-K filing content
Axogen, Inc. completed its acquisition of BioCircuit Technologies, Inc. on October 1, 2026, to expand its medical technology portfolio and enhance surgical solutions for nerve repair.
Key Takeaways
Acquisition of BioCircuit Technologies completed on October 1, 2026, marking a strategic expansion in Axogen's product portfolio
The acquisition is positioned to strengthen Axogen's offerings in surgical solutions for nerve repair within the medical technology sector
2 more takeaways
Related Filings (2)
2 more filings from Axogen, Inc. in the last 90 days
Filing Overview
What This Means
Axogen, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.